350 related articles for article (PubMed ID: 36010664)
1. Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics.
Beltzig L; Christmann M; Kaina B
Cells; 2022 Aug; 11(16):. PubMed ID: 36010664
[TBL] [Abstract][Full Text] [Related]
2. Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells.
Beltzig L; Schwarzenbach C; Leukel P; Frauenknecht KBM; Sommer C; Tancredi A; Hegi ME; Christmann M; Kaina B
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565362
[TBL] [Abstract][Full Text] [Related]
3. Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition.
Rahman M; Olson I; Mansour M; Carlstrom LP; Sutiwisesak R; Saber R; Rajani K; Warrington AE; Howard A; Schroeder M; Chen S; Decker PA; Sananikone EF; Zhu Y; Tchkonia T; Parney IF; Burma S; Brown D; Rodriguez M; Sarkaria JN; Kirkland JL; Burns TC
Mol Cancer Res; 2022 Jun; 20(6):938-948. PubMed ID: 35191501
[TBL] [Abstract][Full Text] [Related]
4. Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance.
Yamamuro S; Takahashi M; Satomi K; Sasaki N; Kobayashi T; Uchida E; Kawauchi D; Nakano T; Fujii T; Narita Y; Kondo A; Wada K; Yoshino A; Ichimura K; Tomiyama A
Cancer Sci; 2021 Nov; 112(11):4736-4747. PubMed ID: 34536314
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
Aasland D; Götzinger L; Hauck L; Berte N; Meyer J; Effenberger M; Schneider S; Reuber EE; Roos WP; Tomicic MT; Kaina B; Christmann M
Cancer Res; 2019 Jan; 79(1):99-113. PubMed ID: 30361254
[TBL] [Abstract][Full Text] [Related]
6. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
He Y; Kaina B
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722
[TBL] [Abstract][Full Text] [Related]
7. Artesunate in glioblastoma therapy: Case reports and review of clinical studies.
Strik H; Efferth T; Kaina B
Phytomedicine; 2024 Jan; 123():155274. PubMed ID: 38142662
[TBL] [Abstract][Full Text] [Related]
8. PARP inhibition suppresses the emergence of temozolomide resistance in a model system.
Yuan AL; Meode M; Tan M; Maxwell L; Bering EA; Pedersen H; Willms J; Liao J; Black S; Cairncross JG; Blough MD
J Neurooncol; 2020 Jul; 148(3):463-472. PubMed ID: 32562246
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells.
Kaina B; Beltzig L; Piee-Staffa A; Haas B
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977591
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
[TBL] [Abstract][Full Text] [Related]
11. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.
Fletcher-Sananikone E; Kanji S; Tomimatsu N; Di Cristofaro LFM; Kollipara RK; Saha D; Floyd JR; Sung P; Hromas R; Burns TC; Kittler R; Habib AA; Mukherjee B; Burma S
Cancer Res; 2021 Dec; 81(23):5935-5947. PubMed ID: 34580063
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma Cells.
Beltzig L; Christmann M; Dobreanu M; Kaina B
Anticancer Res; 2024 Mar; 44(3):901-910. PubMed ID: 38423634
[TBL] [Abstract][Full Text] [Related]
13. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.
Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP
Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275
[TBL] [Abstract][Full Text] [Related]
14. Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence.
Berte N; Lokan S; Eich M; Kim E; Kaina B
Oncotarget; 2016 Oct; 7(41):67235-67250. PubMed ID: 27626497
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
16. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma.
Wu S; Li X; Gao F; de Groot JF; Koul D; Yung WKA
Neuro Oncol; 2021 Jun; 23(6):920-931. PubMed ID: 33433610
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.
Lemasson B; Wang H; Galbán S; Li Y; Zhu Y; Heist KA; Tsein C; Chenevert TL; Rehemtulla A; Galbán CJ; Holland EC; Ross BD
Neoplasia; 2016 Feb; 18(2):82-9. PubMed ID: 26936394
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells.
Filippi-Chiela EC; Thomé MP; Bueno e Silva MM; Pelegrini AL; Ledur PF; Garicochea B; Zamin LL; Lenz G
BMC Cancer; 2013 Mar; 13():147. PubMed ID: 23522185
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells.
Huang BR; Tsai CH; Chen CC; Way TD; Kao JY; Liu YS; Lin HY; Lai SW; Lu DY
Am J Chin Med; 2019; 47(3):657-674. PubMed ID: 30974966
[TBL] [Abstract][Full Text] [Related]
20. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
Stritzelberger J; Distel L; Buslei R; Fietkau R; Putz F
Clin Transl Oncol; 2018 Apr; 20(4):508-516. PubMed ID: 28825189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
